Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-07-19 Sale |
2021-07-21 5:21 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
10,000 | $126.43 | $1,264,348 | 498,558 (Indirect) |
View |
2021-06-29 Sale |
2021-06-30 6:41 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
47,536 | $149.49 | $7,106,341 | 1,581,188 (Indirect Direct) |
View |
2021-06-28 Sale |
2021-06-30 6:38 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
30,375 | $152.48 | $4,631,583 | 158,831 (Indirect Direct) |
View |
2021-06-28 Purchase |
2021-06-30 5:05 pm |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
157,895 | $19 | $3,000,005 | 2,097,938 (Indirect) |
View |
2021-06-11 Sale |
2021-06-15 4:41 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
10,000 | $126.61 | $1,266,118 | 1,575,335 (Indirect Direct) |
View |
2021-03-22 Sale |
2021-03-24 6:00 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
30,374 | $132.37 | $4,020,667 | 1,585,335 (Indirect Direct) |
View |
2021-02-19 Sale |
2021-02-23 4:40 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
171,003 | $149.11 | $25,497,840 | 1,628,724 (Indirect Direct) |
View |
2020-12-16 Sale |
2020-12-18 7:12 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
15,000 | $148.95 | $2,234,266 | 3,040,462 (Indirect Direct) |
View |
2020-12-10 Sale(A) |
2020-12-17 7:14 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
33,000 | $143.35 | $4,730,448 | 3,055,462 (Indirect Direct) |
View |
2020-12-10 Sale |
2020-12-14 7:11 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
33,000 | $143.35 | $4,730,448 | 3,055,462 (Indirect Direct) |
View |
2020-12-07 Sale |
2020-12-09 7:54 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
171,004 | $154.53 | $26,424,505 | 3,088,462 (Indirect Direct) |
View |
2020-11-30 Sale |
2020-12-01 7:13 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
10,393 | $33.15 | $344,513 | 2,138,983 (Indirect Direct) |
View |
2020-11-19 Sale |
2020-11-23 4:39 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
130,017 | $33.01 | $4,291,861 | 6,693,509 (Indirect Direct) |
View |
2020-11-17 Sale |
2020-11-19 9:19 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
4,730 | $33.05 | $156,349 | 6,808,363 (Indirect Direct) |
View |
2020-11-13 Sale |
2020-11-17 7:28 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
4,700 | $33.74 | $158,587 | 6,812,541 (Indirect Direct) |
View |
2020-11-12 Sale |
2020-11-13 7:46 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
15,598 | $34.15 | $532,642 | 5,972,906 (Indirect Direct) |
View |
2020-11-10 Sale |
2020-11-12 5:38 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
39,583 | $34.11 | $1,350,354 | 7,775,016 (Indirect Direct) |
View |
2020-11-06 Sale |
2020-11-10 7:24 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
9,400 | $33.08 | $310,949 | 7,809,983 (Indirect Direct) |
View |
2020-11-04 Sale |
2020-11-06 4:49 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
11,348 | $33.14 | $376,127 | 7,818,286 (Indirect Direct) |
View |
2020-10-26 Sale |
2020-10-28 5:51 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
8,903 | $33.28 | $296,293 | 7,828,310 (Indirect Direct) |
View |
2020-10-15 Sale |
2020-10-20 8:03 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
15,746 | $33.44 | $526,529 | 7,836,175 (Indirect Direct) |
View |
2020-10-13 Sale |
2020-10-15 7:26 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
17,240 | $33.3 | $574,015 | 7,850,084 (Indirect Direct) |
View |
2020-10-08 Sale |
2020-10-13 7:48 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
22,625 | $33.5 | $757,924 | 7,865,313 (Indirect Direct) |
View |
2020-10-06 Sale |
2020-10-08 7:14 pm |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
45,926 | $33.44 | $1,535,732 | 311,881 (Indirect Direct) |
View |
2020-09-18 Sale |
2020-09-22 8:10 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
3,035 | $86.87 | $263,636 | 3,969,319 (Indirect Direct) |
View |
2020-09-16 Sale |
2020-09-18 4:30 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
8,965 | $86.98 | $779,777 | 3,972,354 (Indirect Direct) |
View |
2020-09-14 Sale |
2020-09-16 8:00 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
1,155 | $84.89 | $98,045 | 3,981,319 (Indirect Direct) |
View |
2020-09-10 Sale |
2020-09-11 9:49 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
22,845 | $85.36 | $1,949,996 | 2,152,425 (Indirect Direct) |
View |
2020-09-01 Sale |
2020-09-03 9:21 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
60,000 | $92.51 | $5,550,644 | 4,223,064 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-06-09 Option Award |
2022-06-10 5:35 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
12,000 | $0 | 12,000 (Direct) |
View |
2021-06-28 Other |
2021-06-30 6:41 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
1,416,648 | $0 | 1,581,188 (Indirect) |
View |
2021-06-28 Conversion |
2021-06-30 5:05 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
38,309,520 | $0 | 2,097,938 (Indirect) |
View |
2021-02-24 Option Award |
2021-06-25 5:00 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
3,575,000 | $2 | 9,896,460 (Indirect) |
View |
2021-06-23 Option Award |
2021-06-25 5:00 pm |
N/A 2031-06-22 |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
47,132 | $0 | 9,896,460 (Direct) |
View |
2021-03-11 Option Award |
2021-06-25 5:00 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
2,699,328 | $2.9637 | 9,896,460 (Indirect) |
View |
Ownership |
2021-06-23 8:47 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
0 | $0 | 8,739,158 (Indirect) |
View |
2021-06-18 Option Award |
2021-06-22 6:12 pm |
N/A 2031-06-17 |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:36 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-03-01 Other |
2021-03-03 4:23 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
407,434 | $0 | 1,365,779 (Indirect) |
View |
2021-02-19 Other |
2021-02-23 4:40 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
1,416,648 | $0 | 1,628,724 (Indirect) |
View |
2020-12-14 Other |
2020-12-16 6:58 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
21,412 | $0 | 5,650,304 (Indirect) |
View |
2020-11-27 Other |
2020-12-01 7:13 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
443,053 | $0 | 2,138,983 (Indirect) |
View |
2020-11-23 Other |
2020-11-25 4:45 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
792,763 | $0 | 832,615 (Indirect) |
View |
2020-11-11 Other |
2020-11-13 7:46 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
989,754 | $0 | 5,972,906 (Indirect) |
View |
2020-10-29 Other |
2020-11-02 5:30 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
536,996 | $0 | 2,566,055 (Indirect) |
View |
2020-10-07 Other |
2020-10-08 7:14 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
300,522 | $0 | 311,881 (Indirect) |
View |
2020-09-22 Other |
2020-09-24 6:09 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
429,596 | $0 | 2,421,474 (Indirect) |
View |
2020-09-17 Other |
2020-09-21 7:51 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
758,523 | $0 | 784,495 (Indirect) |
View |
2020-09-09 Other |
2020-09-11 9:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
214,799 | $0 | 2,152,425 (Indirect) |
View |
2020-09-01 Exercise |
2020-09-03 9:21 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
15,000 | $59.31 | 4,223,064 (Indirect) |
View |
2020-09-01 Exercise |
2020-09-03 9:21 pm |
N/A 2026-10-18 |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
60,000 | $0 | 4,223,064 (Indirect) |
View |
2020-09-01 Exercise |
2020-09-03 9:21 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
15,000 | $13.62 | 4,223,064 (Indirect) |
View |
2020-09-01 Exercise |
2020-09-03 9:21 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
30,000 | $14 | 4,223,064 (Indirect) |
View |